#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myeloproliferative neoplasm Extranodal marginal zone B-cell lymphoma (MALT type) Frontotemporal dementia Neuromyelitis optica spectrum disorder Ewing's sarcoma recurrent Cortical dysplasia Neutropenia Anaplastic large cell lymphoma T- and null-cell types Glomerulonephritis acute Glomerulonephritis membranous Human papilloma virus immunisation Thrombotic thrombocytopenic purpura Gaucher's disease type I Leukoencephalopathy Neuroendocrine tumour More trials…

    Learn about Rare Diseases

    MELAS syndrome – Life with Disease Primary biliary cholangitis – Trials in Disease Pleural mesothelioma malignant – Trials in Disease Pleural mesothelioma malignant – Treatment Pelizaeus-Merzbacher disease Pituitary-dependent Cushing’s syndrome – Diagnostics Rhabdoid tumour Cerebral arteriovenous malformation haemorrhagic – Diagnostics Alternating hemiplegia of childhood – Basic Information Cholangitis sclerosing – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alnuctamab Dexamethasone Acetate Ph. Eur. Levocarnitine Burfiralimab Tafluprost Vibegron Sar-443579 Fluoxetine Hydrochloride Budesonide Betula Pendula Pollen Extract Mosunetuzumab Paliperidone Sym025 Paraffin White Soft Lurasidone Sodium Fluoride (18F) AGALSIDASE BETA Anb032 ANHYDROUS CALCIUM FOLINATE NIZUBAGLUSTAT More therapies…

    Learn about Your Condition

    Drug eruption Uveitis Coeliac disease Immunodeficiency Papillary thyroid cancer Hairy cell leukaemia recurrent Skin ulcer Mitral valve prolapse Triple negative breast cancer C3 glomerulopathy Graft infection Adenocarcinoma of colon Aicardi-Goutieres syndrome Urinary tract infection Primary biliary cholangitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Menopausal symptoms

  • Study on the Effects of DHEA and Melatonin on Sleep and Mood in Postmenopausal Women with Sleep Disorders

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Menopause
    • Sleep disorder
    Investigated Drugs:
    • Prasterone
    • Melatonin
    Poland

  • Study on the Effects of Estradiol, Progesterone, and Online Sleep Therapy for Insomnia and Menopausal Symptoms in Perimenopausal Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Insomnia
    Investigated Drugs:
    • Estradiol
    • Progesterone, Micronised
    The Netherlands

  • Study on the Required Dose of Cholecalciferol for Managing Vitamin D Deficiency in Postmenopausal Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Vitamin D deficiency
    Investigated Drugs:
    • Colecalciferol
    Spain

  • Study on the Safety of Micronized Progesterone and Norethisterone Acetate with Estradiol for Menopausal Symptoms in Women

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Estradiol
    • NORETHISTERONE ACETATE
    • Progesterone, Micronised
    Sweden

  • Relative bioavailability and safety of elinzanetant soft‑gel capsules in healthy adults for vasomotor symptoms

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Testosterone deficiency syndrome
    • Hot flush
    Investigated Drugs:
    • Elinzanetant
    Germany

  • Study on the Effects of Estetrol Monohydrate on Hair Growth in Postmenopausal Women with Hair Loss

    Not recruiting

    2 1
    Germany
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!